Immunotherapy of endometrial cancer via CD47 blockade-mediated macrophage phagocytosis

被引:0
作者
Yucebas, Kerem [1 ]
Ko, Sooah [1 ]
Zhou, Jinyu [1 ]
Hamel, Elizabeth M. [1 ]
Hackworth, Mia G. [1 ,2 ]
Diaz Miranda, Edgar Andres [1 ]
Carpenter, Haley S. [1 ]
Hunter, Mark, I [1 ]
Khan, Omair M. [3 ,4 ]
Weissman, Irving L. [3 ,4 ]
Jin, Shiying [1 ]
机构
[1] Univ Missouri, Sch Med, Dept Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA
[2] Univ Missouri, Coll Arts & Sci, Columbia, MO 65211 USA
[3] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA
[4] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA
来源
PNAS NEXUS | 2025年 / 4卷 / 05期
基金
美国国家卫生研究院;
关键词
CD47; macrophage; phagocytosis; immunotherapy; endometrial cancer; Biological Sciences; Medical Sciences; PROTEIN; RITUXIMAB; IMMUNITY; TARGET; CELLS;
D O I
10.1093/pnasnexus/pgaf143
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The interaction between CD47 expressed on cancer cells and signal regulatory protein-alpha located on macrophages blocks the phagocytosis of tumor cells by macrophages. Our data reveal that human endometrial cancer cells (hECCs) upregulate the CD47 level on their surface and that there is a high density of tumor-associated macrophages within the microenvironment of human endometrial cancer. In vitro functional assay shows that an anti-CD47 monoclonal antibody (mAb) promotes the phagocytosis of hECCs by macrophages. Systemic and in situ treatments with an anti-CD47 mAb effectively reduce tumor burden in vivo in a genetically engineered mouse model of endometrial cancer. Thus, this study provides preclinical evidence that CD47 blockade using an anti-CD47 mAb to augment macrophage phagocytosis is a potential therapeutic strategy for endometrial cancer.
引用
收藏
页数:11
相关论文
共 47 条
[1]   CD47 Blockade by Hu5F9-G4 and Rituximab in Non-Hodgkin's Lymphoma [J].
Advani, Ranjana ;
Flinn, Ian ;
Popplewell, Leslie ;
Forero, Andres ;
Bartlett, Nancy L. ;
Ghosh, Nilanjan ;
Kline, Justin ;
Roschewski, Mark ;
LaCasce, Ann ;
Collins, Graham P. ;
Thu Tran ;
Lynn, Judith ;
Chen, James Y. ;
Volkmer, Jens-Peter ;
Agoram, Balaji ;
Huang, Jie ;
Majeti, Ravindra ;
Weissman, Irving L. ;
Takimoto, Chris H. ;
Chao, Mark P. ;
Smith, Sonali M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (18) :1711-1721
[2]   Why consider vaginal drug administration? [J].
Alexander, NJ ;
Baker, E ;
Kaptein, M ;
Karck, U ;
Miller, L ;
Zampaglione, E .
FERTILITY AND STERILITY, 2004, 82 (01) :1-12
[3]   CXCR2 inhibition in G-MDSCs enhances CD47 blockade for melanoma tumor cell clearance [J].
Banuelos, Allison ;
Zhang, Allison ;
Berouti, Hala ;
Baez, Michelle ;
Yilmaz, Leyla ;
Georgeos, Nardin ;
Marjon, Kristopher D. ;
Miyanishi, Masanori ;
Weissman, Irving L. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2024, 121 (05)
[4]   CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy [J].
Barkal, Amira A. ;
Brewer, Rachel E. ;
Markovic, Maxim ;
Kowarsky, Mark ;
Barkal, Sammy A. ;
Zaro, Balyn W. ;
Krishnan, Venkatesh ;
Hatakeyama, Jason ;
Dorigo, Oliver ;
Barkal, Layla J. ;
Weissman, Irving L. .
NATURE, 2019, 572 (7769) :392-+
[5]   Adding immunotherapy to first-line treatment of advanced and metastatic endometrial cancer [J].
Bogani, G. ;
Monk, B. J. ;
Powell, M. A. ;
Westin, S. N. ;
Slomovitz, B. ;
Moore, K. N. ;
Eskander, R. N. ;
Raspagliesi, F. ;
Barretina-Ginesta, M. -P ;
Colombo, N. ;
Mirza, M. R. .
ANNALS OF ONCOLOGY, 2024, 35 (05) :414-428
[6]   Integrin-associated protein (CD47) and its ligands [J].
Brown, EJ ;
Frazier, WA .
TRENDS IN CELL BIOLOGY, 2001, 11 (03) :130-135
[7]   Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma [J].
Chao, Mark P. ;
Alizadeh, Ash A. ;
Tang, Chad ;
Myklebust, June H. ;
Varghese, Bindu ;
Gill, Saar ;
Jan, Max ;
Cha, Adriel C. ;
Chan, Charles K. ;
Tan, Brent T. ;
Park, Christopher Y. ;
Zhao, Feifei ;
Kohrt, Holbrook E. ;
Malumbres, Raquel ;
Briones, Javier ;
Gascoyne, Randy D. ;
Lossos, Izidore S. ;
Levy, Ronald ;
Weissman, Irving L. ;
Majeti, Ravindra .
CELL, 2010, 142 (05) :699-713
[8]   Colony-stimulating factor-1 in immunity and inflammation [J].
Chitu, V ;
Stanley, ER .
CURRENT OPINION IN IMMUNOLOGY, 2006, 18 (01) :39-48
[9]  
Cho Nicholas, 2021, Oncotarget, V12, P2039, DOI 10.18632/oncotarget.28074
[10]   Endometrial cancer [J].
Crosbie, Emma J. ;
Kitson, Sarah J. ;
McAlpine, Jessica N. ;
Mukhopadhyay, Asima ;
Powell, Melanie E. ;
Singh, Naveena .
LANCET, 2022, 399 (10333) :1412-1428